News | June 23, 2021
Shilpa Medicare launches dissolving oral thin films of Paracetamol
Shilpa's Paracetamol oral thin films are patent protected and are first of this kind in the world
Shilpa's Paracetamol oral thin films are patent protected and are first of this kind in the world
In an exclusive interview with Rahul Koul of Indian Chemical News, Priyanka Chigurupati, Executive Director, Granules Pharmaceuticals Inc. USA shared details about the company's performance, R&D initiatives, Capex plan, CSR, and future outlook. Excerpts of the interview:
Sun Pharma is granted rights for co-marketing of the drug in India in the private market under the brand name CARITEC
Mucormycosis drug AmphoTLC will be imported from Taiwan by Stelis Biopharma Private Limited (Stelis), the biotech arm of Strides group, and will be launched and distributed in India immediately by Strides
Dr. Sharvil Patel cites the example of prescriptions being handed over to patients despite unavailability of enough stock of such medicines
The roller coaster ride during the pandemic has taken Indian pharmaceutical industry through a lot of bitter sweet experiences.
With the surge of infections in India in the recent days AmphoTLC will address the country's acute liposomal amphotericin B shortage
Number of approved manufacturing sites of Remdesivir in the country has increased from 22 sites to 60
A total quantum of more than 4.39 crore doses was also available for direct procurement by the states as well as private hospitals in the month of May 2021
The company will provide one crore tablets every week, starting from 12th May 2021, aggregating to 16 crore tablets worth Rs. 8 crores over the next 4 months
Subscribe To Our Newsletter & Stay Updated
